New developments in aminoglycoside therapy and ototoxicity.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Hearing Research

• Publication date

  2011-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.heares.2011.05.008PMID 21640178PMCID PMC3169717
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Canadian guidelines for rhinosinusitis: practical tools for the busy clinician

  2012cited by this paper
• Aminoglycosides Inhibit KCNQ4 Channels in Cochlear Outer Hair Cells via Depletion of Phosphatidylinositol(4,5)bisphosphate

  2011influential reference
• American Academy of Audiology Position Statement and Clinical Practice Guidelines Ototoxicity Monitoring

  2011cited by this paper
• Current use of aminoglycosides: indications, pharmacokinetics and monitoring for toxicity

  2011cited by this paper
• Aminoglycoside antibiotics cochleotoxicity in paediatric cystic fibrosis (CF) patients: A study using extended high-frequency audiometry and distortion product otoacoustic emissions

  2011influential reference
• Gentamicin‐induced readthrough of stop codons in duchenne muscular dystrophy

  2010cited by this paper
• Fine tuning gene expression: the epigenome.

  2010cited by this paper
• Treatment of Pulmonary Exacerbations in Adult Cystic Fibrosis Patients: A Review

  2010cited by this paper
• Extensively Drug-Resistant Tuberculosis: A Sign of the Times and an Impetus for Antimicrobial Discovery

  2010influential reference
• Management of Aminoglycosides in the Intensive Care Unit

  2010cited by this paper
• Daily Compared With 8-Hour Gentamicin for the Treatment of Intrapartum Chorioamnionitis: A Randomized Controlled Trial

  2010cited by this paper
• Aminoglycosides redesign strategies for improved antibiotics and compounds for treatment of human genetic diseases.

  2010cited by this paper
• Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis.

  2010cited by this paper
• Drug screening for hearing loss: using the zebrafish lateral line to screen for drugs that prevent and cause hearing loss.

  2010cited by this paper
• Combating evolution with intelligent design: the neoglycoside ACHN-490.

  2010cited by this paper
• Evaluation of amphiphilic aminoglycoside-peptide triazole conjugates as antibacterial agents.

  2010cited by this paper
• Development of novel aminoglycoside (NB54) with reduced toxicity and enhanced suppression of disease-causing premature stop mutations.

  2009cited by this paper
• Generation of highly-reactive oxygen species is closely related to hair cell damage in rat organ of Corti treated with gentamicin.

  2009cited by this paper
• Bcl-2 Gene Therapy Prevents Aminoglycoside-Induced Degeneration of Auditory and Vestibular Hair Cells

  2009cited by this paper
• Aminoglycoside Ototoxicity in Nicaraguan children: Patient risk Factors and Mitochondrial DNA Results

  2009cited by this paper
• Cystic Fibrosis

  2009cited by this paper
• Hsp70 inhibits aminoglycoside-induced hearing loss and cochlear hair cell death

  2009cited by this paper
• Can aspirin protect or at least attenuate gentamicin ototoxicity in humans?

  2009cited by this paper
• Aminoglycoside‐induced histone deacetylation and hair cell death in the mouse cochlea

  2009influential reference
• Tetany in kala azar patients treated with paromomycin.

  2008cited by this paper
• Ampicillin Resistance and Outcome Differences in Acute Antepartum Pyelonephritis

  2008cited by this paper
• Tetany in kala azar patients treated with paromomycin.

  2008cited by this paper
• Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial.

  2008cited by this paper
• Histone deacetylase inhibitors in cancer therapy: latest developments, trends and medicinal chemistry perspective.

  2007cited by this paper
• Gentamicin-induced ototoxicity in hemodialysis patients is ameliorated by N-acetylcysteine.

  2007cited by this paper
• Blocking c-Jun-N-terminal kinase signaling can prevent hearing loss induced by both electrode insertion trauma and neomycin ototoxicity.

  2007cited by this paper
• Does vitamin E prevent gentamicin-induced ototoxicity?

  2007cited by this paper
• Is gentamicin ototoxic to the fetus?

  2007cited by this paper
• Dual action-based approaches to antibacterial agents.

  2007cited by this paper
• Injectable paromomycin for Visceral leishmaniasis in India.

  2007cited by this paper
• Aspirin to prevent gentamicin-induced hearing loss.

  2006cited by this paper
• Aminoglycoside-induced reduction in nucleotide mobility at the ribosomal RNA A-site as a potentially key determinant of antibacterial activity.

  2006influential reference
• Rac/Rho pathway regulates actin depolymerization induced by aminoglycoside antibiotics

  2006influential reference
• Caspase-independent pathways of hair cell death induced by kanamycin in vivo

  2006influential reference
• A PI3K Pathway Mediates Hair Cell Survival and Opposes Gentamicin Toxicity in Neonatal Rat Organ of Corti

  2006cited by this paper
• Side effects due to primary antituberculosis drugs during the initial phase of therapy in 1149 hospitalized patients for tuberculosis.

  2006cited by this paper
• Kanamycin alters cytoplasmic and nuclear phosphoinositide signaling in the organ of Corti in vivo

  2006influential reference
• Effect of some simple manoeuvres on the course of acute renal failure after gentamycin treatment in rats

  2005cited by this paper
• Ototoxicity: therapeutic opportunities.

  2005cited by this paper
• Molecular insights into aminoglycoside action and resistance.

  2005cited by this paper
• Branched aminoglycosides: biochemical studies and antibacterial activity of neomycin B derivatives.

  2005cited by this paper
• The aminoglycoside antibiotic dihydrostreptomycin rapidly enters mouse outer hair cells through the mechano 
‐electrical transducer channels

  2005cited by this paper
• TRPV1 regulators mediate gentamicin penetration of cultured kidney cells.

  2005cited by this paper
• NF‐κB pathway protects cochlear hair cells from aminoglycoside‐induced ototoxicity

  2005cited by this paper
• Readthrough of dystrophin stop codon mutations induced by aminoglycosides

  2004cited by this paper
• Antioxidant gene therapy can protect hearing and hair cells from ototoxicity.

  2004cited by this paper
• Salicylate reduces cisplatin nephrotoxicity by inhibition of tumor necrosis factor-alpha.

  2004cited by this paper
• Isolation of an aminoglycoside receptor from guinea pig inner ear tissues and kidney

  2004cited by this paper
• Cystic fibrosis

  2003cited by this paper
• Distribution of Gentamicin in the Guinea Pig Inner Ear after Local or Systemic Application

  2003cited by this paper
• A Peptide Inhibitor of c-Jun N-Terminal Kinase Protects against Both Aminoglycoside and Acoustic Trauma-Induced Auditory Hair Cell Death and Hearing Loss

  2003cited by this paper
• Comparative vestibulotoxicity of different aminoglycosides in the Guinea pigs.

  2003cited by this paper
• Identification of sodium salicylate as an hsp inducer using a simple screening system for stress response modulators in mammalian cells.

  2003cited by this paper
• The Effect of Vecuronium Is Enhanced by a Large Rather than a Modest Dose of Gentamicin as Compared with No Preoperative Gentamicin

  2003cited by this paper
• Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations.

  2003cited by this paper
• Contribution of the MexXY Multidrug Transporter to Aminoglycoside Resistance in Pseudomonas aeruginosa Clinical Isolates

  2003cited by this paper
• Involvement of ras activation in toxic hair cell damage of the mammalian cochlea.

  2003cited by this paper
• Hearing loss and nephrotoxicity treatment in patients with in long-term aminoglycoside tuberculosis

  2002influential reference
• Blockade of c-Jun N-terminal kinase pathway attenuates gentamicin-induced cochlear and vestibular hair cell death

  2002cited by this paper
• Blockade of c-Jun N-terminal kinase pathway attenuates gentamicin-induced cochlear and vestibular hair cell death.

  2002cited by this paper
• Hearing loss and nephrotoxicity in long-term aminoglycoside treatment in patients with tuberculosis.

  2002cited by this paper
• Aminoglycoside ototoxicity in adult CBA, C57BL and BALB mice and the Sprague-Dawley rat.

  2001cited by this paper
• Individualized Pharmacokinetic Monitoring Results in Less Aminoglycoside‐Associated Nephrotoxicity and Fewer Associated Costs

  2001cited by this paper
• Evidence that systemic gentamicin suppresses premature stop mutations in patients with cystic fibrosis.

  2001cited by this paper
• Aminoglycoside-mediated suppression of nonsense mutations in late infantile neuronal ceroid lipofuscinosis.

  2001cited by this paper
• Structural basis for selectivity and toxicity of ribosomal antibiotics

  2001cited by this paper
• Occurrence and Risk of Cochleotoxicity in Cystic Fibrosis Patients Receiving Repeated High-Dose Aminoglycoside Therapy

  2001cited by this paper
• Differential vulnerability of basal and apical hair cells is based on intrinsic susceptibility to free radicals.

  2001cited by this paper
• Gentamicin treatment of Duchenne and Becker muscular dystrophy due to nonsense mutations

  2001cited by this paper
• Temporal Bone Studies of the Human Peripheral Vestibular System

  2000cited by this paper
• Intratympanic Gentamicin for the Treatment of Unilateral Meniere's Disease

  2000cited by this paper
• Antioxidants attenuate gentamicin-induced free radical formation in vitro and ototoxicity in vivo: D-methionine is a potential protectant.

  2000cited by this paper
• Rescue of Hearing, Auditory Hair Cells, and Neurons by CEP-1347/KT7515, an Inhibitor of c-Jun N-Terminal Kinase Activation

  2000cited by this paper
• Temporal Bone Studies of the Human Peripheral Vestibular System

  2000cited by this paper
• Salicylate attenuates gentamicin-induced ototoxicity.

  1999influential reference
• Formation of reactive oxygen species following bioactivation of gentamicin.

  1999influential reference
• Correction of genetic disease by making sense from nonsense.

  1999cited by this paper
• Hair Cell Protection from Aminoglycoside Ototoxicity by Adenovirus-Mediated Overexpression of Glial Cell Line-Derived Neurotrophic Factor

  1999cited by this paper
• Ultrastructural localization of megalin in the rat cochlear duct.

  1999cited by this paper
• Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice.

  1999cited by this paper
• Iron chelators protect from aminoglycoside-induced cochleo- and vestibulo-toxicity.

  1998cited by this paper
• Lysosomal targeting and accumulation of aminoglycoside antibiotics in sensory hair cells.

  1997cited by this paper
• Morphological evidence of ototoxicity of the iron chelator deferoxamine.

  1997cited by this paper
• Reactive oxygen species in chick hair cells after gentamicin exposure in vitro.

  1997cited by this paper
• Myosin VIIA Is Required for Aminoglycoside Accumulation in Cochlear Hair Cells

  1997cited by this paper
• Variable efficacy of radical scavengers and iron chelators to attenuate gentamicin ototoxicity in guinea pig in vivo.

  1996cited by this paper
• Improved survival in the Danish center‐treated cystic fibrosis patients: Results of aggressive treatment

  1996cited by this paper
• Direct detection of ototoxicant-induced reactive oxygen species generation in cochlear explants.

  1996cited by this paper
• Evidence that epithelial glycoprotein 330/megalin mediates uptake of polybasic drugs.

  1995cited by this paper
• Formation of free radicals by gentamicin and iron and evidence for an iron/gentamicin complex.

  1995cited by this paper
• Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases

  1995cited by this paper
• Urinary tract infection during pregnancy: its association with maternal morbidity and perinatal outcome.

  1994cited by this paper
• Mitochondrial ribosomal RNA mutation associated with both antibiotic–induced and non–syndromic deafness

  1993cited by this paper
• Early detection of ototoxicity using high-frequency, tone-burst-evoked auditory brainstem responses.

  1992cited by this paper
• Cellular and subcellular localization of tritiated gentamicin in the guinea pig cochlea following combined treatment with ethacrynic acid.

  1992cited by this paper

• Ototoxicité médicamenteuse

  2026cites this paper
• Turning on fluorescent probe for sensitive detection of streptomycin in pure, pharmaceutical formulations and human plasma

  2026cites this paper
• Translational framework combining machine learning and in vivo screening for aminoglycoside ototoxicity prevention.

  2026cites this paper
• Pathophysiological insights and therapeutic developments in age-related hearing loss: a narrative review

  2025cites this paper
• Ethacrynic acid regulates gentamicin ototoxicity via the blood-labyrinth barrier.

  2025cites this paper
• Molecular Mechanisms of Aminoglycoside-Induced Ototoxicity in Murine Auditory Cells: Implications for Otoprotective Drug Development

  2025cites this paper
• Preliminary Analysis of Drug-Induced Ototoxicity in South Korea: Trends From a National Sample Dataset

  2025cites this paper
• Isolated from Populus euphratica rhizosphere soil, and mining their metabolites

  2025cites this paper
• Residue and Human Risk: A Reassessment of Aminoglycoside Residues in Edible Tissues

  2025cites this paper
• An update on ototoxicity: from a genetic perspective.

  2025cites this paper
• Advances in auricular drug delivery for the management of different otitic conditions.

  2025cites this paper
• The Effect of Antibiotics on the Nervous System: Importance for Anesthesiology and Intensive Care

  2025cites this paper
• Polymer-Lipid Hybrid Nanoparticles for Enhanced Gentamicin Efficacy Against Drug-Resistant Bacteria

  2025cites this paper
• Maternal Exposure to Medications and the Risk of Congenital and Early‐Onset Hearing Loss in Children: A Systematic Review and a Meta‐Analysis

  2025cites this paper
• Ototoxicity: a high risk to auditory function that needs to be monitored in drug development

  2024cites this paper
• Ivacaftor attenuates gentamicin-induced ototoxicity through the CFTR-Nrf2-HO1/NQO1 pathway

  2024cites this paper
• Genetic Variations and Antibiotic-Related Adverse Events

  2024cites this paper
• Aminoglycoside heteroresistance in Enterobacter cloacae is driven by the cell envelope stress response

  2024cites this paper
• Protective Effects of Gastrodin Against Gentamicin-Induced Vestibular Damage by the Notch Signaling Pathway

  2024cites this paper
• A New Perspective to Interpret How the Vestibular Efferent System Correlates the Complexity of Routine Balance Maintenance with Management of Emergency Fall Prevention Strategies

  2024cites this paper
• Re-telling the story of aminoglycoside ototoxicity: tales from sub-Saharan Africa

  2024influential citation
• Design, Synthesis and Activity Evaluation Against Drug‐Resistant Bacteria of 6’‐Amidine Modified Aminoglycoside Derivatives

  2024cites this paper
• A Consolidated Understanding of the Contribution of Redox Dysregulation in the Development of Hearing Impairment

  2024cites this paper
• Role of Memantine in Limiting Cochleotoxicity in Rats

  2024cites this paper
• Characterization of 3,3′-iminodipropionitrile (IDPN) damaged utricle transcriptome in the adult mouse utricle

  2024cites this paper
• Integrated Preparation of Hollow Lignin Nanoparticles as a Drug Carrier and Levulinic Acid from the Poplar Wood Prehydrolysis Liquor.

  2024cites this paper
• Predictive model for aminoglycoside induced ototoxicity

  2024cites this paper
• Insights into the molecular underlying mechanisms and therapeutic potential of endoplasmic reticulum stress in sensorineural hearing loss

  2024cites this paper
• Ototoxic and nephrotoxic drugs in neonatal intensive care units: results of a Spanish and Italian survey

  2024cites this paper
• Aminoglycosides: single- or multiple-daily dosing? An updated qualitative systematic review of randomized trials on toxicity and efficacy.

  2023cites this paper
• Aminoglycoside heteroresistance in Enterobacter cloacae is driven by the cell envelope stress response

  2023cites this paper
• The Relevance of Autophagy within Inner Ear in Baseline Conditions and Tinnitus-Related Syndromes

  2023cites this paper
• Otoprotection against aminoglycoside- and cisplatin-induced ototoxicity focusing on the upstream drug uptake pathway

  2023cites this paper
• Development of Chinese herbal medicine for sensorineural hearing loss

  2023cites this paper
• Recoding of Nonsense Mutation as a Pharmacological Strategy

  2023cites this paper
• Age-related hearing loss and its potential drug candidates: a systematic review

  2023cites this paper
• Protective effects of nigella sativa oil against gentamicin-induced ototoxicity in rats: A dose-ranging study.

  2023cites this paper
• Aminoglycosides-Related Ototoxicity: Mechanisms, Risk Factors, and Prevention in Pediatric Patients

  2023cites this paper
• Physicochemical properties of otic products for Canine Otitis Externa: comparative analysis of marketed products

  2023cites this paper
• MRPL12-ANT3 interaction involves in acute kidney injury via regulating MPTP of tubular epithelial cells

  2023cites this paper
• Immunotherapy and immunochemotherapy in combating visceral leishmaniasis

  2023cites this paper
• Ototoxicity of Aminoglycosides the Modern Concepts

  2023cites this paper
• Off Target Toxicities and Links with Physicochemical Properties of Medicinal Products, including Antibiotics, Oligonucleotides, Lipid nanoparticles (with cationic and/or anionic charges). Data review suggests an emerging pattern.

  2023cites this paper
• Protective role of pyrroloquinoline quinone against gentamicin induced cochlear hair cell ototoxicity

  2023cites this paper
• 6’-sialyllactose ameliorates the ototoxic effects of the aminoglycoside antibiotic neomycin in susceptible mice

  2023cites this paper
• Colistin- and Amikacin-loaded lipid-based drug delivery systems for resistant gram-negative lung and wound bacterial infections.

  2023cites this paper
• Otoprotective Effects of Fucoidan Reduce Cisplatin-Induced Ototoxicity in Mouse Cochlear UB/OC-2 Cells

  2023cites this paper
• Risk assessment of Enterococcus faecium, Klebsiella pneumoniae, and Pseudomonas aeruginosa in environmental water sources: Development of surrogate models for antibiotic resistance genes.

  2023cites this paper
• Small-molecule eRF3a degraders rescue CFTR nonsense mutations by promoting premature termination codon readthrough

  2022cites this paper
• Assessing the Clinical Value of Objective and Patient-Reported Audiovestibular Outcome Measures in the Risk Estimation of Systemic Cobalt Toxicity for Patients With a Metal-on-Metal Hip Implant

  2022cites this paper
• Curcumin-Encapsulated Chitosan-Coated Nanoformulation as an Improved Otoprotective Strategy for Ototoxic Hearing Loss.

  2022cites this paper
• Evaluation and comparison of antibiotic susceptibility profiles of Streptomyces spp. from clinical specimens revealed common and region-dependent resistance patterns

  2022cites this paper
• Tigecycline and Gentamicin-Combined Treatment Enhances Renal Damage: Oxidative Stress, Inflammatory Reaction, and Apoptosis Interplay

  2022cites this paper
• Tetrandrine Prevents Neomycin-Induced Ototoxicity by Promoting Steroid Biosynthesis

  2022cites this paper
• Aminoglycoside treatment alters hearing-related genes and depicts behavioral defects in Drosophila.

  2022cites this paper
• The Antibiotic Resistance and Multidrug Resistance Pattern of Uropathogenic Escherichia coli at Soba University Hospital: A Descriptive Retrospective Survey

  2022cites this paper
• Novel Application of Eupatilin for Effectively Attenuating Cisplatin-Induced Auditory Hair Cell Death via Mitochondrial Apoptosis Pathway

  2022cites this paper
• Analysis of potential protective effects of caffeic acid phenethyl ester against gentamicin ototoxicity: An experimental study

  2022cites this paper
• Downstream Alternate Start Site Allows N-Terminal Nonsense Variants to Escape NMD and Results in Functional Recovery by Readthrough and Modulator Combination

  2022cites this paper
• A longitudinal community-based ototoxicity monitoring programme and treatment effects for drug-resistant tuberculosis treatment, Western Cape

  2022cites this paper
• Bronchiectasis and inhaled tobramycin: A literature review.

  2022cites this paper
• Hippo/YAP signaling pathway protects against neomycin-induced hair cell damage in the mouse cochlea

  2022cites this paper
• An Overview of Nanoparticle Drug Delivery for Ototoxin and Noise Mediated Hearing Loss Treatment

  2022cites this paper
• Amphiphilic aminoglycosides: Modifications that revive old natural product antibiotics

  2022cites this paper
• Salicylate attenuates gentamicin-induced ototoxicity and facilitates the recovery in the basilar papilla of the lizard Podarcis siculus.

  2022cites this paper
• Medical Therapy of Hearing Impairment and Tinnitus with Chinese Medicine: An Overview

  2022cites this paper
• Elucidation of the mechanism of miR-122-5p in mediating FOXO3 injury and apoptosis of mouse cochlear hair cells induced by hydrogen peroxide

  2022cites this paper
• Autophagy: A Novel Horizon for Hair Cell Protection

  2021cites this paper
• Effect of Diabetes Mellitus on Renal and Audiology Toxicities in Patients with Drug-Resistant Pulmonary Tuberculosis

  2021cites this paper
• Mechanism and Prevention of Ototoxicity Induced by Aminoglycosides

  2021cites this paper
• Gentamicin-induced hearing loss: A retrospective study using the Food and Drug Administration Adverse Event Reporting System and a toxicological study using drug−gene network analysis

  2021cites this paper
• Effect of Diabetes Mellitus on Renal and Audiology Toxicities in Patients with Drug-Resistant Pulmonary Tuberculosis

  2021cites this paper
• Reducing the Toxicity of Designer Aminoglycosides as Nonsense Mutation Readthrough Agents for Therapeutic Targets.

  2021cites this paper
• Icariin Treatment Protects Against Gentamicin-Induced Ototoxicity via Activation of the AMPK-SIRT3 Pathway

  2021cites this paper
• Using the Zebrafish Lateral Line to Understand the Roles of Mitochondria in Sensorineural Hearing Loss

  2021cites this paper
• Hearing Loss: Environmental, Sensorineural, Drug Induced (Cisplatin, Antibiotics)

  2021cites this paper
• Early hearing threshold changes and peculiarities of audiometric assessments among patients in a drug-resistant tuberculosis treatment center

  2021cites this paper
• Aminoglycoside- and glycopeptide-induced ototoxicity in children: a systematic review

  2021cites this paper
• In Vitro Evaluations of the Effects on Chitosan Paste by the Derivatization of Chitosan

  2021cites this paper
• Exposure to colistin impairs skin keratinocytes and lateral-line hair cells in zebrafish embryos.

  2021cites this paper
• A scoping review of global aminoglycoside antibiotic overuse: A potential opportunity for primary ototoxicity prevention.

  2021cites this paper
• Antioxidant Effect of Curcumin on the Prevention of Oxidative Damage to the Cochlea in an Ototoxic Rat Model Based on Malondialdehyde Expression

  2021cites this paper
• Community-Based Ototoxicity Monitoring for Drug-Resistant Tuberculosis in South Africa: An Evaluation Study

  2021cites this paper
• Robust W1282X-CFTR rescue by a small molecule GSPT1 degrader

  2021cites this paper
• Targeting Autophagy Induction as A possible Protective Mechanism by Verapamil Compared to Rapamycin (Sirolimus) Against Gentamicin -Induced Ototoxicity in Guinea Pigs

  2021cites this paper
• Systemic toll-like receptor 9 agonist CpG oligodeoxynucleotides exacerbates aminoglycoside ototoxicity.

  2021cites this paper
• Neuromuscular Junction Disorders and Floppy Infant Syndrome: A Comprehensive Review

  2020cites this paper
• Comparison Of The Effectiveness Of Alpha- Tocopherol And Ginkgo Biloba Extract On The Prevention Of Ototoxic Kanamycin In The Treatment Of Multiple Drug-Resistant Tuberculosis

  2020cites this paper
• Ebselen attenuates tobramycin-induced ototoxicity in mice.

  2020cites this paper
• Liproxstatin-1 Protects Hair Cell-Like HEI-OC1 Cells and Cochlear Hair Cells against Neomycin Ototoxicity

  2020cites this paper
• Drug‐induced hearing loss: a case/non‐case study in the French pharmacovigilance database

  2020cites this paper
• Systemic Fluorescent Gentamicin Enters Neonatal Mouse Hair Cells Predominantly Through Sensory Mechanoelectrical Transduction Channels

  2020cites this paper
• Therapeutic Drug Monitoring by Pharmacists: Does It Reduce Costs.

  2020cites this paper
• Cytotoxic effect of aminoglycoside antibiotics on the mammalian cell lines

  2020cites this paper
• Understanding the characteristics of nonspecific binding of drug-like compounds to canonical stem–loop RNAs and their implications for functional cellular assays

  2020cites this paper
• A Novel Active Peptide from Rapana venosa Protects Against Gentamicin-Induced Sensory Hair Cell Loss in Zebrafish

  2020cites this paper
• Nanocarriers for drug delivery to the inner ear: physicochemical key parameters, biodistribution, safety and efficacy.

  2020cites this paper
• A Novel Active Peptide from Rapana venosa Protects Against Gentamicin-Induced Sensory Hair Cell Loss in Zebrafish

  2020cites this paper
• The effects of hyperbaric oxygen therapy on an experimental cisplatin-induced ototoxicity model

  2020cites this paper
• Revealing the high propensity of RNAs to non-specifically bind drug-like small molecules

  2020cites this paper